Exome Asset Management LLC
- SEC CIK
- 0002011932
- Latest filing
- Aug 14, 2026
APRE holding history
Aprea Therapeutics, Inc. in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APRE overviewAll 13F holders of APREFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −28,972−100.0% | Sold out | Holders |
| Q1 2025 | 28,972 | $59.1K | 0.1% | −98,988−77.4% | Reduced | Holders |
| Q4 2024 | 127,960 | $419.7K | 0.3% | −9,214−6.7% | Reduced | Holders |
| Q3 2024 | 137,174 | $377.2K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 137,174 | $558.3K | 0.5% | +137,174 | New | Holders |